Company intelligence / Profile preview

Bisu

Ownership: Private
Employees: ~18
Development stage: Preclinical

Overview

Bisu has developed a home-use diagnostic device called the "Bisu Body Coach," which uses disposable microfluidic test sticks to analyze urine and saliva for multiple biomarkers. The system provides personalized nutrition and lifestyle advice via a smartphone app. As of the latest reports, the product was in beta testing with additional test sticks under development for broader applications including training intensity monitoring and pet/baby health. No clinical trial results are published as this is a consumer diagnostic/lifestyle product.

Therapeutic areas: Metabolic DisordersNephrologyOther
Modalities: Device (microfluidic "lab-on-a-chip" technology)
Industry: Metabolite Diagnostics

Partnerships

ASICS Corporation/Ventures – strategic partnership on fitness/wellness initiatives

Beyond the preview

Go deeper on Bisu.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bisu.

Explore the full profile